Baker Brothers Life Sciences Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.75 | 550,000 | 12,513,765 | 5,773,365 | 5.2 M to 5.8 M (+10.53 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.44 | 115,000 | 2,695,060 | 5,223,365 | 5.1 M to 5.2 M (+2.25 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.17 | 117,273 | 2,717,344 | 5,108,365 | 5 M to 5.1 M (+2.35 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.81 | 58,388 | 1,331,976 | 4,991,092 | 4.9 M to 5 M (+1.18 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.51 | 1,948 | 43,845 | 4,932,704 | 4.9 M to 4.9 M (+0.04 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.86 | 48,657 | 1,112,299 | 4,930,756 | 4.9 M to 4.9 M (+1.00 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.88 | 86,227 | 1,972,693 | 4,882,099 | 4.8 M to 4.9 M (+1.80 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.05 | 10,996 | 253,503 | 4,795,872 | 4.8 M to 4.8 M (+0.23 %) |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 33,130,000 | 371,668,905 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | D | 11.22 | 42,509,000 | 476,887,217 | 0 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | A | 8.78 | 124,687,000 | 1,094,751,860 | 124,687,000 | |
| Sep 28 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Grant | A | 6.75 | 1,848,200 | 12,475,350 | 8,929,705 | 7.1 M to 8.9 M (+26.10 %) |
| Aug 16 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 37,070 | 150,134 | 4,149,611 | 4.1 M to 4.1 M (+0.90 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 106,622 | 429,591 | 4,112,541 | 4 M to 4.1 M (+2.66 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 2,559 | 10,313 | 4,005,919 | 4 M to 4 M (+0.06 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 1,038 | 4,190 | 4,003,360 | 4 M to 4 M (+0.03 %) |
| Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.70 | 23,576 | 87,208 | 3,734,541 | 3.7 M to 3.7 M (+0.64 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 36,328 | 147,125 | 3,978,746 | 3.9 M to 4 M (+0.92 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 159,019 | 644,027 | 3,942,418 | 3.8 M to 3.9 M (+4.20 %) |
| Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 7,414 | 30,010 | 3,783,399 | 3.8 M to 3.8 M (+0.20 %) |
| Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 28,692 | 115,746 | 3,775,985 | 3.7 M to 3.8 M (+0.77 %) |
| Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 17,793 | 72,058 | 3,747,293 | 3.7 M to 3.7 M (+0.48 %) |
| Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 18,535 | 74,079 | 3,729,500 | 3.7 M to 3.7 M (+0.50 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 4,935,126 | 3,207,832 | 8,381,925 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 608,343 | 395,423 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 505,590 | 328,634 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 3,821,193 | 2,483,775 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 6,580,168 | 0 | 11,175,900 | 4.6 M to 11.2 M (+143.18 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 811,124 | 0 | 0 | 811.1 K to 0 (-100.00 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 674,120 | 0 | 0 | 674.1 K to 0 (-100.00 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 5,094,924 | 0 | 0 | 5.1 M to 0 (-100.00 %) |
| Sep 11 2006 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.17 | 187,370 | 2,655,707 | 713,044 | 525.7 K to 713 K (+35.64 %) |
| Sep 11 2006 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.12 | 12,541 | 177,020 | 525,674 | 513.1 K to 525.7 K (+2.44 %) |
| Sep 11 2006 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.42 | 37,325 | 500,916 | 513,133 | 475.8 K to 513.1 K (+7.84 %) |
| Apr 28 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 1,228,857 | 0 | 1,228,857 | 0 to 1.2 M |
| Apr 28 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 84,102 | 0 | 0 | 84.1 K to 0 (-100.00 %) |
| Apr 28 2006 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 1,144,755 | 0 | 0 | 1.1 M to 0 (-100.00 %) |
| Apr 28 2006 | NPRO | TAPESTRY PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 319,355 | 0 | 1,844,485 | 1.5 M to 1.8 M (+20.94 %) |
| Apr 28 2006 | NPRO | TAPESTRY PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 264,874 | 0 | 0 | 264.9 K to 0 (-100.00 %) |
| Apr 28 2006 | NPRO | TAPESTRY PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 54,481 | 0 | 0 | 54.5 K to 0 (-100.00 %) |
| Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.08 | 61,443 | 250,491 | 3,710,965 | 3.6 M to 3.7 M (+1.68 %) |
| Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.02 | 233,645 | 938,645 | 3,649,522 | 3.4 M to 3.6 M (+6.84 %) |
| Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 96,673 | 390,250 | 3,415,877 | 3.3 M to 3.4 M (+2.91 %) |
| Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.03 | 1,072 | 4,320 | 3,319,204 | 3.3 M to 3.3 M (+0.03 %) |
| Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 103,552 | 414,374 | 3,318,132 | 3.2 M to 3.3 M (+3.22 %) |
| Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.07 | 26,145 | 106,342 | 3,214,580 | 3.2 M to 3.2 M (+0.82 %) |
| Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.05 | 15,005 | 60,797 | 3,188,435 | 3.2 M to 3.2 M (+0.47 %) |
| Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.06 | 8,239 | 33,459 | 3,173,430 | 3.2 M to 3.2 M (+0.26 %) |
| Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.07 | 36,983 | 150,643 | 3,165,191 | 3.1 M to 3.2 M (+1.18 %) |
| Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 21,409 | 85,561 | 3,128,208 | 3.1 M to 3.1 M (+0.69 %) |
| Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.99 | 27,367 | 109,235 | 3,106,799 | 3.1 M to 3.1 M (+0.89 %) |
| Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 23,585 | 94,290 | 3,079,432 | 3.1 M to 3.1 M (+0.77 %) |
| Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 6,361 | 25,417 | 3,055,847 | 3 M to 3.1 M (+0.21 %) |
| Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.04 | 29,202 | 118,107 | 3,049,486 | 3 M to 3 M (+0.97 %) |
| Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.02 | 39,543 | 158,809 | 3,020,284 | 3 M to 3 M (+1.33 %) |
| Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.90 | 18,491 | 72,115 | 2,980,741 | 3 M to 3 M (+0.62 %) |
| Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.00 | 1,393,286 | 5,573,144 | 2,962,250 | 1.6 M to 3 M (+88.80 %) |
| Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.11 | 53,921 | 221,615 | 1,568,964 | 1.5 M to 1.6 M (+3.56 %) |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 284,115 | 0 | 284,115 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 34,385 | 0 | 0 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 0.00 | 249,730 | 0 | 0 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 355,143 | 2,219,644 | 355,143 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 42,981 | 268,631 | 0 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | J | 6.25 | 312,162 | 1,951,013 | 0 | |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 448,047 | 0 | 682,908 | 234.9 K to 682.9 K (+190.77 %) |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 45,090 | 0 | 0 | 45.1 K to 0 (-100.00 %) |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 49,807 | 0 | 0 | 49.8 K to 0 (-100.00 %) |
| Apr 28 2006 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 353,150 | 0 | 0 | 353.2 K to 0 (-100.00 %) |
| Apr 28 2006 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 2,307,661 | 0 | 2,307,661 | 0 to 2.3 M |
| Apr 28 2006 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 268,465 | 0 | 0 | 268.5 K to 0 (-100.00 %) |
| Apr 28 2006 | NRGN | NEUROGEN CORP | Baker Brothers Life Sciences C ... | Director | Sell | J | 0.00 | 2,039,196 | 0 | 0 | 2 M to 0 (-100.00 %) |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.00 | 63 | 0 | 63 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.00 | 7 | 0 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.00 | 56 | 0 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 2.07 | 34,410 | 71,091 | 34,410 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 10.85 | 4,050 | 43,943 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 10.85 | 30,360 | 329,406 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 2.07 | 165,725 | 342,388 | 165,725 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 2.07 | 18,414 | 38,043 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 2.07 | 147,311 | 304,345 | 0 | |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 517,593 | 0 | 608,152 | 90.6 K to 608.2 K (+571.55 %) |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 15,928 | 0 | 0 | 15.9 K to 0 (-100.00 %) |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 56,491 | 0 | 0 | 56.5 K to 0 (-100.00 %) |
| Apr 28 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 445,174 | 0 | 0 | 445.2 K to 0 (-100.00 %) |
Page: 1